UCLA Jonsson Comprehensive Cancer Center
@UCLAHealthJCCC
Followers
276
Following
556
Media
41
Statuses
426
Official account for the UCLA Jonsson Comprehensive Cancer Center, a leader in cancer care, research and education.
Los Angeles, CA
Joined August 2024
UCLA researchers have developed a powerful new cell therapy that attacks triple-negative breast cancer from multiple angles and can be mass-produced from donated stem cells, making it an accessible, off-the-shelf treatment option. Learn more:
uclahealth.org
UCLA researchers have developed a CAR-NKT cell therapy that has shown to be more effective than current immunotherapies at fighting cancer in tumor samples from late-stage triple-negative breast...
0
2
4
A new UCLA study found women with early-stage cervical cancer who received radiation + chemotherapy reported a greater short-term drop in quality of life than those who received radiation alone, highlighting the need for supportive care during treatment. https://t.co/lS3JrJI0Jx
uclahealth.org
A new study co-led by investigators at UCLA Health found that women with early-stage cervical cancer who received radiation plus chemotherapy reported a greater short-term decline in quality of life...
0
2
3
This @JAMAOnc piece was big 4 me in so many ways;🔎the intersectionality of breast CA & HF risk with #bcsm @UCLAHealthJCCC guru #PattiGanz who got me into #cardioonc with this important study by pioneer @AnaBaracCardio who has done so much for the field & for me. 🙏@ICOSociety
Editorial: Cardiac surveillance recommendations after breast cancer treatment remain limited, with evidence suggesting most survivors benefit from primary care focused on prevention and management of traditional cardiovascular risk factors. https://t.co/rnQqFZCgWt
1
7
33
Congratulations to Dr. Antoni Ribas, who was named the 17th Annual Weinman Award recipient for his pioneering research that led to novel and effective therapies for metastatic melanoma, a disease once considered untreatable. https://t.co/lxbiFBAnER
uclahealth.org
Dr. Ribas was named the 17th Annual Weinman Award recipient in recognition of his pioneering research that led to the development of novel and effective therapies for patients with metastatic...
0
1
5
WATCH🎥: Jeremie Calais, MD, (@CalaisJeremie) highlights key findings from the phase 2 LUNAR trial, evaluating 177Lu-PSMA therapy neoadjuvant to SBRT in omHSPC. #ESMO25 @UclaUrology
urologytimes.com
Jeremie Calais, MD, PhD, shares key findings from the phase 2 LUNAR trial, assessing the safety and efficacy of adding 177Lu-PSMA therapy before SBRT in omHSPC.
0
1
3
A UCLA-led study in @TheLancet shows that combining zanzalintinib with the immunotherapy drug atezolizumab improves survival for patients with advanced colorectal cancer, the first immunotherapy benefit for most with this disease. #ESMO25
https://t.co/3B2J3zzLWa
uclahealth.org
A new study led by UCLA found that combining zanzalintinib and atezolizumab helped patients with metastatic colorectal cancer live longer and control their disease better than with the standard...
0
3
8
UCLA investigators shared new research at #ESMO25, including 10-year survival data for lung cancer immunotherapy, a new PSMA-targeted therapy for recurrent prostate cancer, and promising advances in colorectal and bladder cancers. Read more:
uclahealth.org
Investigators from the UCLA Health Jonsson Comprehensive Cancer Center will present new research at the ESMO Congress, covering advances in immunotherapy, targeted therapies, and new combination...
0
2
6
👀 Older women should continue to get #mammograms “if they’re healthy and want to stay healthy.” @DrNimmiKapoor of @dgsomucla shares striking data: Screening before #BreastCancer diagnosis sharply lowers risk of death and recurrence. https://t.co/0qiEkjqCJm
healio.com
Older age should not stop women from getting mammograms.A retrospective analysis found women with breast cancer aged at least 80 years had a 55% lower risk for recurrence and more than 70% lower risk...
0
1
4
Indeed! Mammograms for our healthy 80 year olds are important. Thank you @HemOncToday @UCLAHealth @UCLAHealthJCCC for highlighting our work.
👀 Older women should continue to get #mammograms “if they’re healthy and want to stay healthy.” @DrNimmiKapoor of @dgsomucla shares striking data: Screening before #BreastCancer diagnosis sharply lowers risk of death and recurrence. https://t.co/0qiEkjqCJm
0
3
10
Congratulations to Dr. Jingran Ji, who recently received an NIH-funded GEMSSTAR award that will help support his research into how cancer treatments affect physical function and quality of life in older adults with gastroesophageal cancer. https://t.co/yTaGX2zfAP
uclahealth.org
The award will support Ji’s research into how cancer treatments affect physical function and quality of life in older adults with gastroesophageal cancer.
0
0
6
🧠 AI-assisted lesion tracking on whole-body PET captures the 🧬 heterogeneity of metastatic cancer — one lesion at a time. 📉 Some shrink, 📈 others grow, ✨ new ones appear. Quantifying these dynamics helps predict therapy response & survival. 👉 https://t.co/sXNKkvhEtg
AI–assisted lesion-tracking analysis of PSMA PET is prognostic for overall survival in patients with #mCRPC undergoing PSMA radiopharmaceutical therapy. https://t.co/TMYYhZ6J78
#NuclearMedicine #RPTherapy #AI @VMurthymed @CalaisJeremie @DrAGafita
2
13
34
Dr. Amar Kishan honored with Steven A. Leibel Memorial Award
newsroom.ucla.edu
The award recognizes outstanding principal investigators within the first decade of their careers following board certification.
0
2
8
🎨 Join us for AYA Paint Day! Sat, Oct 11 at 12 p.m. Hosted by the AYA Oncology Program + United on Campus (UCLA). Connect, relax & create art with other young adults. 💛 Spots limited — RSVP here: https://t.co/YW5qQTv7OR
0
1
2
With support from @AmericanCancer, cancer patients, survivors & caregivers participated in art therapy led by @simmsmannucla and hosted at the @chargers training facility. The event is part of #CrucialCatch, demonstrating the power of community. Read more: https://t.co/x3Cty0Rsg5
0
2
4
A team of researchers led by @davidulmert has identified a promising new treatment strategy that can detect, kill & reprogram aggressive, treatment-resistant tumors like osteosarcomas & glioblastoma. https://t.co/HVb5RbCFvS
uclahealth.org
UCLA scientists, together with a team of international collaborators, have identified a promising new treatment strategy that can detect, kill and reprogram aggressive, treatment-resistant tumors...
0
3
5
Congratulations to Dr. David Ulmert @davidulmert and team for the promising new LRRC15-targeting radionuclide therapy for aggressive, treatment-resistant tumors!
uclahealth.org
UCLA scientists, together with a team of international collaborators, have identified a promising new treatment strategy that can detect, kill and reprogram aggressive, treatment-resistant tumors...
0
3
2
Congratulations to Dr. Linda Liau, @DGSOMUCLA professor and chair of neurosurgery, and @UCLAHealthJCCC investigator, for receiving the J.E. Wallace Sterling Lifetime Achievement Award in Medicine from the Stanford Medicine Alumni Association. Learn more: https://t.co/OXxbQL3Zlo
0
7
18
New therapy delays progression of recurrent prostate cancer, @UCLA study shows https://t.co/KfB4LKnXzW
cancerletter.com
Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic body radiotherapy went more than twice as long without their disease worsen...
1
2
1
Very proud of @UCLA_Alumni Fred Ramsdell for receiving the #NobelPrize in physiology or medicine — our 17th Nobel Prize for an alumnus or faculty member, and the third prize in five years for a Bruin.
chancellor.ucla.edu
Chancellor Frenk shared a message with the Bruin community. Dear Bruin Community: We are delighted to share that UCLA alumnus Fred Ramsdell has been awarded the 2025 Nobel Prize in physiology or...
7
26
114
This year’s medicine laureate Fred Ramsdell was born in 1960. He received his Ph.D. in 1987 from @UCLA, Los Angeles, USA. He is currently a scientific advisor at @sonomabio in San Francisco, USA. https://t.co/0tgOr2wZbr
#NobelPrize
26
220
1K